Emergent BioSolutions Inc.EBSNYSE
LOADING
|||
Switch Symbol:
Year-over-year earnings per share growth rate
| Period | Value |
|---|---|
| Q3 2025 | 536.36% |
| Q2 2025 | -117.60% |
| Q1 2025 | 311.86% |
| Q4 2024 | -127.31% |
| Q3 2024 | 140.15% |
| Q2 2024 | -3264.71% |
| Q1 2024 | 117.89% |
| Q4 2023 | 81.48% |
| Q3 2023 | 0.39% |
| Q2 2023 | -41.10% |
| Q1 2023 | -107.39% |
| Q4 2022 | -15.79% |
| Q3 2022 | -34.51% |
| Q2 2022 | -1447.95% |
| Q1 2022 | -102.06% |
| Q4 2021 | 680.33% |
| Q3 2021 | -777.78% |
| Q2 2021 | -93.13% |
| Q1 2021 | -62.68% |
| Q4 2020 | 368.00% |
| Q3 2020 | -57.39% |
| Q2 2020 | 833.33% |
| Q1 2020 | -126.37% |
| Q4 2019 | 8.33% |
| Q3 2019 | 566.67% |
| Q2 2019 | 64.71% |
| Q1 2019 | -663.47% |
| Q4 2018 | -115.90% |
| Q3 2018 | -58.00% |
| Q2 2018 | 1100.00% |
| Q1 2018 | -112.99% |
| Q4 2017 | -4.94% |
| Q3 2017 | 636.36% |
| Q2 2017 | -57.69% |
| Q1 2017 | -67.50% |
| Q4 2016 | 53.85% |
| Q3 2016 | 292.59% |
| Q2 2016 | -370.00% |
| Q1 2016 | -88.24% |
| Q4 2015 | -9.57% |